Dr. Jason Fangusaro, MD
Claim this profileChildren's Healthcare of Atlanta - Egleston
Expert in Brain Tumor
Studies Brain Cancer
17 reported clinical trials
28 drugs studied
About Jason Fangusaro, MD
Education:
- Earned an MD from Loyola University Stritch School of Medicine, Chicago, Illinois.
Experience:
- Completed Residency at Lutheran General Children's Hospital, Chicago, Illinois.
- Undertook a Pediatric Hematology/Oncology Fellowship at Nationwide Children's Hospital, Columbus, Ohio.
- Completed a Pediatric Neuro-Oncology Fellowship at Children's Hospital of Los Angeles, California.
- Currently a Professor in the Department of Pediatrics at Emory University School of Medicine.
- Serves as the Director of Developmental Therapeutics at the Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta.
- Holds the position of Pediatric Neuro-Oncologist in the Pediatric Oncology Research Program – Discovery and Developmental Therapeutics.
Area of expertise
1Brain Tumor
Global LeaderNF1 positive
NTRK1 positive
NTRK positive
2Brain Cancer
Stage IV
BRAF negative
Stage I
Affiliated Hospitals
Clinical Trials Jason Fangusaro, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Jason Fangusaro, MD
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jason Fangusaro, MD has experience with
- Selumetinib
- Avutometinib
- Hydroxychloroquine
- Dabrafenib
- Trametinib
- APX005M
Breakdown of trials Jason Fangusaro, MD has run
Brain Tumor
Brain Cancer
Solid Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jason Fangusaro, MD specialize in?
Jason Fangusaro, MD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved NF1 positive patients, or patients who are NTRK1 positive.
Is Jason Fangusaro, MD currently recruiting for clinical trials?
Yes, Jason Fangusaro, MD is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Jason Fangusaro, MD has studied deeply?
Yes, Jason Fangusaro, MD has studied treatments such as Selumetinib, Avutometinib, Hydroxychloroquine.
What is the best way to schedule an appointment with Jason Fangusaro, MD?
Apply for one of the trials that Jason Fangusaro, MD is conducting.
What is the office address of Jason Fangusaro, MD?
The office of Jason Fangusaro, MD is located at: Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia 30322 United States. This is the address for their practice at the Children's Healthcare of Atlanta - Egleston.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.